Lv4
798 积分 2024-10-14 加入
DARPins Recognizing the Tumor-Associated Antigen EpCAM Selected by Phage and Ribosome Display and Engineered for Multivalency
16天前
已完结
Recent Development of Peptide Drugs and Advance on Theory and Methodology of Peptide Inhibitor Design
23天前
已完结
Novel Constructs—Half-Life Extensions
1个月前
已完结
A Phase 1a/b, Open-label, Dose-escalation Study of the Safety, Pharmacokinetics, and Initial Efficacy of 225Ac-ABD147 in Patients with Small Cell Lung Cancer and Large Cell Neuroendocrine Carcinoma of the Lung Following Platinum-based Chemotherapy
1个月前
已关闭
Novel Constructs—Half-Life Extensions
1个月前
已完结
5 Oral: Preliminary Results from a Phase Ia/Ib, Open-label, Multicenter Study of ZL-1310, a DLL3-targeted ADC, to Evaluate the Safety, Tolerability, and Pharmacokinetics in Subjects with Small Cell Lung Cancer - NCT06179069
1个月前
已完结
A DLL3-targeted theranostic for small cell lung cancer: Imaging a low density target with a site-specifically modified radioimmunoconjugate
1个月前
已关闭
ImmunoPET in high-grade neuroendocrine tumours
1个月前
已完结
MC339, a novel radiopharmaceutical, targets DLL3-expressing cancers of different tissue origins
1个月前
已完结
皖公网安备34019202002308
